Points to consider to promote adherence in people with RMDs

Prevent non-adherence by building trust, overcoming barriers, and tailoring the solution to the problem. INTRODUCTION Rheumatic and musculoskeletal diseases (often shortened to RMDs) are a group of diseases that affect the joints and muscles. There are lots of different treatments available that can both treat symptoms, and stop some of the underlying disease processes. Most […]

Read More…

Self-managing your inflammatory arthritis

This is the lay version of the EULAR recommendations for self-management in people with types of inflammatory arthritis. The original publication can be downloaded from the EULAR website: www.eular.org. Nikiphorou E, et al. 2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis. Ann Rheum Dis 2021;0:1-8. doi:10.1136/annrheumdis-2021-220249 Introduction EULAR recommendations […]

Read More…

Increased COVID-19 risk in autoimmune disease, but not more severe

People with autoimmune disease have an increased risk of getting infected with COVID-19, especially if they use steroid medicines. However, the risk of severe outcomes of COVID-19 such as hospitalisation or death is not increased. INTRODUCTION COVID-19 is the disease caused by a new type of coronavirus called severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). It […]

Read More…

COVID-19-related death in rheumatic diseases

This is the lay version of a paper published on behalf of the COVID-19 Global Rheumatology Alliance Consortium. It examines COVID-19-related death in people with rheumatic diseases. The original publication can be downloaded from the EULAR website: www.eular.org. Strangfeld A, et al. Factors Associated with COVID-19-related Death in People with Rheumatic Diseases: Results from the […]

Read More…

Managing irAEs with checkpoint inhibitors

This is the lay version of the EULAR ‘points to consider’ for the diagnosis and management of rheumatic immune-related side effects in people taking checkpoint inhibitors for cancer. The original publication can be downloaded from the EULAR website: www.eular.org. Kostine M, et al. EULAR points to consider for the diagnosis and management of rheumatic immune-related […]

Read More…

Managing PsA with pharmacological therapies

This is the lay version of the 2019 update of the EULAR recommendations for the management of psoriatic arthritis using pharmacological medicines. The original publication can be downloaded from the EULAR website: www.eular.org. Gossec L, et al. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update. Ann Rheum Dis 2020;79:700–712. doi:10.1136/annrheumdis-2020-217159 […]

Read More…

Sjögren’s syndrome

This is the lay version of the EULAR recommendations for the use of topical and systemic treatments in people with Sjögren’s syndrome. The original publication can be downloaded from the EULAR website: www.eular.org. Ramos-Casals M, et al. EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies. Ann Rheum Dis 2020;79:3–18. doi:10.1136/annrheumdis-2019-216114 Introduction […]

Read More…

Vaccination for people with AIIRD

This is the lay version of the EULAR recommendations for vaccination in adults with autoimmune inflammatory rheumatic diseases (often shortened to AIIRD). The original publication can be downloaded from the EULAR website: www.eular.org. Furer V, et al. 2019 Update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 2020 […]

Read More…

The role of the nurse in inflammatory arthritis

This is the lay version of the updated EULAR recommendations for the role of the nurse in managing chronic inflammatory arthritis. The original publication can be downloaded from the EULAR website: www.eular.org. Bech B, et al. 2018 update of the EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritis. […]

Read More…

Managing antiphospholipid syndrome

This is the lay version of the EULAR recommendations for the management of antiphospholipid syndrome in adults. The original publication can be downloaded from the EULAR website: www.eular.org. Tektonidou MG, et al. EULAR recommendations for the management of antiphospholipid syndrome in adults Ann Rheum Dis 2019;78(10):1296–1304. doi:10.1136/annrheumdis-2019-215213 Introduction EULAR recommendations give advice to doctors, nurses […]

Read More…